Antitumor properties of aloe-emodin and induction of transglutaminase 2 activity in B16-F10 melanoma cells

Life Sciences

Volumn 87, Issue 9-10, 2010, Pages 316-324

  Tabolacci, Claudio ^a   Lentini, Alessandro ^a   Mattioli, Palma ^a   Provenzano, Bruno ^a   Oliverio, Serafina ^a   Carlomosti, Fabrizio ^a   Beninati, Simone ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Aloe emodin; Melanogenesis; Melanoma; Metastasis; Transglutaminase

Indexed keywords

ALOE EMODIN; GELATINASE B; MELANIN; MONOPHENOL MONOOXYGENASE; POLYAMINE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; PROTOPORPHYRIN;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL ADHESION; CELL AGGREGATION; CELL COUNT; CELL DIFFERENTIATION; CELL INVASION; CELL LEVEL; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; IN VITRO STUDY; MELANOMA CELL; MOUSE; NONHUMAN;

ANIMALS; ANTHRAQUINONES; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL ADHESION; CELL AGGREGATION; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; ENZYME INDUCTION; GTP-BINDING PROTEINS; INTRAMOLECULAR OXIDOREDUCTASES; MATRIX METALLOPROTEINASES; MELANINS; MELANOMA, EXPERIMENTAL; MICE; PROTOPORPHYRINS; TRANSGLUTAMINASES;

ALOE; MURINAE;

EID: 77955776103     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2010.07.003     Document Type: Article

References (45)

1. Akimov S.S., Krylov D., Fleischman L.B., Belkin A.M. Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. The Journal of Cell Biology 2000, 148(4):825-838.
2. Albini A., Iwamoto Y., Kleinman H.K., Martin G.R., Aaronson S.A., Kozlowski J.M., McEwan R.N. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Research 1987, 47(12):3239-4325.
3. Beninati S. Post-translational modification of protein in cancer cells: the transglutaminase catalysed reactions. The Cancer Journal 1995, 8:234-236.
4. Beninati S., Piacentini M. The transglutaminase family: an overview. Amino Acids 2004, 26(4):367-372.
5. Beninati S., Abbruzzese A., Cardinali M. Differences in the post-translational modification of proteins by polyamines between weakly and highly metastatic B16 melanoma cells. International Journal of Cancer 1993, 53(5):792-797.
6. Beninati S., Senger D.R., Cordella-Miele E., Mukherjee A.B., Chackalaparampil I., Shanmugam V., Singh K., Mukherjee B.B. Osteopontin: its transglutaminase-catalyzed posttranslational modifications and cross-linking to fibronectin. The Journal of Biochemistry 1994, 115(4):675-682.
7. Casero R.A., Pegg A.E. Polyamine catabolism and disease. Biochemical Journal 2009, 421:323-338.
8. Chau D.Y., Collighan R.J., Verderio E.A., Addy V.L., Griffin M. The cellular response to transglutaminase-cross-linked collagen. Biomaterials 2005, 26(33):6518-6529.
9. Cho N.H., Shim H.S., Rha S.Y., Kang S.H., Hong S.H., Choi Y.D., Hong S.J., Cho S.H. Increased expression of matrix metalloproteinase 9 correlates with poor prognostic variables in renal cell carcinoma. European Urology 2003, 44(5):560-566.
10. Chung S.I., Folk J.E. Transglutaminase from hair follicle of guinea pig (crosslinking-fibrin-glutamyllysine-isoenzymes-purified enzyme). Proceedings of the National Academy of Sciences of the United States of America 1972, 69(2):303-307.
11. Condello S., Caccano D., Currò M., Ferlazzo N., Parisi G., Ientile R. Transglutaminase 2 and NF-kappaB interplay during NGF-induced differentiation of neuroblastoma cells. Brain Research 2008, 1207:1-8.
12. Dai H., Kramer D.L., Yang C., Murti K.G., Porter C.W., Cleveland J.L. The polyamine oxidase inhibitor MDL-72527 selectively induces apoptosis of transformed hematopoietic cells through lysosomotropic effects. Cancer Research 1999, 59:4944-4954.
13. Fidler I.J. Selection of successive tumor cell lines for metastasis. Nature: New Biology 1973, 242(118):148-149.
14. Gismondi A., Lentini A., Tabolacci C., Provenzano B., Beninati S. Transglutaminase-dependent antiproliferative and differentiative properties of nimesulide on B16-F10 mouse melanoma cells. Amino Acids 2010, 38(1):257-262.
15. Guo J.M., Xiao B.X., Liu Q., Zhang S., Liu D.H., Gong Z.H. Anticancer effect of aloe-emodin on cervical cancer cells involves G2/M arrest and induction of differentiation. Acta Pharmacologica Sinica 2007, 28(12):1991-1995.
16. Hara M., Yaar M., Gilchrest B.A. Endothelin-1 of keratinocyte origin is a mediator of melanocyte dendricity. Journal of Investigative Dermatology 1995, 105(6):744-748.
17. Huang Q., Lu G., Shen H.M., Chung M.C., Ong C.N. Anti-cancer properties of anthraquinones from Rhubarb. Medicinal Research Reviews 2007, 27(5):609-630.
18. Ickowicz Schwartz D., Gozlan Y., Greenbaum L., Babushkina T., Katcoff D.J., Malik Z. Differentiation-dependent photodynamic therapy regulated by porphobilinogen deaminase in B16 melanoma. British Journal of Cancer 2004, 90(9):1833-1841.
19. Jones R.A., Kotsakis P., Johnson T.S., Chau D.Y., Ali S., Melino G., Griffin M. Matrix changes induced by transglutaminase 2 lead to inhibition of angiogenesis and tumor growth. Cell Death & Differentiation 2006, 13(9):1442-1453.
20. Kam Y., Guess C., Estrada L., Weidow B., Quaranta V. A novel circular invasion assay mimics in vivo behavior of cancer cell lines and distinguishes single-cell motility in vitro. BMC Cancer 2008, 8:198.
21. Kuo P.L., Lin T.C., Lin C.C. The antiproliferative activity of aloe-emodin is through p53-dependent and p21-dependent apoptotic pathway in human hepatoma cell lines. Life Sciences 2002, 71(16):1879-1892.
22. Lee H.Z., Hsu S.L., Liu M.C., Wu C.H. Effects and mechanisms of aloe-emodin on cell death in human lung squamous cell carcinoma. European Journal of Pharmacology 2001, 431(3):287-295.
23. Lentini A., Abbruzzese A., Caraglia M., Marra M., Beninati S. Protein-polyamine conjugation by transglutaminase in cancer cell differentiation: review article. Amino Acids 2004, 26(4):331-337.
24. Lentini A., Provenzano B., Caraglia M., Shevchenko A., Abbruzzese A., Beninati S. Impairment of the metastatic activity of melanoma cells by transglutaminase-catalyzed incorporation of polyamines into laminin and Matrigel. Amino Acids 2008, 34(2):251-256.
25. Lentini A., Provenzano B., Tabolacci C., Beninati S. Protein-polyamine conjugates by transglutaminase 2 as potential markers for antineoplastic screening of natural compounds. Amino Acids 2009, 36(4):701-708.
26. Lotan R., Lotan D. Stimulation of melanogenesis in a human melanoma cell by retinoids. Cancer Research 1980, 40(9):3345-3350.
27. Mijatovic S., Maksimovic-Ivanic D., Radovic J., et al. Anti-glioma action of aloe emodin: the role of ERK inhibition. Cellular and Molecular Life Sciences 2005, 62(5):589-598.
28. Morgan DML. Measurement of aldehyde formation as a assay for polyamine oxidase activity. Polyamine protocols (Chapter 12). In: D. Morgan Humana Press Inc (Ed). Methods in Molecular Biology: Polyamine Protocols, Vol 79. Totowa, NJ, USA, pp.105-108, 1998.
29. Ohno R., Yoshida H., Fukutani H., Naoe T., Ohshima T., Kyo T., Endoh N., Fujimoto T., Kobayashi T., Hiraoka A., et al. Multi-institutional study of all-trans-retinoic acid as a differentiation therapy of refractory acute promyelocytic leukemia. Leukaemia Study Group of the Ministry of Health and Welfare. Leukemia 1993, 7(11):1722-1727.
30. Pecere T., Gazzola M.V., Mucignat C., Parolin C., Vecchia F.D., Cavaggioni A., Basso G., Diaspro A., Salvato B., Carli M., Palù G. Aloe-emodin is a new type of anticancer agent with selective activity against neuroectodermal tumors. Cancer Research 2000, 60(11):2800-2804.
31. Quash G., Keolouangkhot T., Gazzolo L., Ripoll H., Saez S. Diamine oxidase and polyamine oxidase activities in normal and transformer cells. Biochemical Journal 1979, 177(1):275-282.
32. Riley P.A. Melanogenesis: a realistic target for antimelanoma theraphy?. European Journal of Cancer 1992, 27(9):1172-1177.
33. Russell D., Snyder S.H. Amine synthesis in rapidly growing tissues: ornithine decarboxylase activity in regenerating rat liver, chick embryo, and various tumors. Proceedings of the National Academy of Sciences of the United States of America 1968, 60(4):1420-1427.
34. Sabeh F., Ota I., Holmbeck K., Birkedal-Hansen H., Soloway P., Balbin M., Lopez-Otin C., Shapiro S., Inada M., Krane S., Allen E., Chung D., Weiss S.J. Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP. The Journal of Cell Biology 2004, 167(4):769-781.
35. Sato K., Takahashi H., Iraha R., Toriyama Down-regulation of tyrosinase expression by acetylsalicylic acid in murine B16 melanoma. Biological & Pharmaceutical Bulletin 2008, 31(1):33-37.
36. Seiler N. Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 2. Structural analogues and derivatives. Current Drug Targets 2003, 4(7):565-585.
37. Seo K., Mohanty T.R., Choi T., Hwang I. Biology of epidermal and hair pigmentation in cattle: a mini-review. Veterinary Dermatology 2007, 18(6):392-400.
38. Tabor C.W., Tabor H. Polyamines in microorganisms. Microbiological Reviews 1985, 49(1):81-99.
39. Takashi R. A novel actin label: a fluorescent probe at glutamine-41 and its consequences. Biochemistry 1988, 27(3):938-943.
40. Tee A.E., Marshall G.M., Liu P.Y., Xu N., Haber M., Norris M.D., Iismaa S.E., Liu T. Opposing effects of two tissue transglutaminase protein isoforms in neuroblastoma cell differentiation. The Journal of Biological Chemistry 2010, 285(6):3561-3567.
41. Thiele C.J., Gore S., Collins S., Waxman S., Miller W. Differentiate or die: the view from Montreal. Cell Death & Differentiation 2000, 7(10):1014-1017.
42. Tsuboi T., Kondoh H., Hiratsuka J., Mishima Y. Enhanced melanogenesis induced by tyrosinase gene-transfer increases boron-uptake and killing effect of boron neutron capture therapy for amelanotic melanoma. Pigment Cell Research 1998, 11(5):275-278.
43. Wallace H.M., Fraser A.V., Hughes A. A perspective of polyamine metabolism. Biochemical Journal 2003, 376:1-14.
44. Wolf K., Mazo I., Leung H., Engelke K., von Andrian U.H., Deryugina E.I., Strongin A.Y., Bröcker E.B., Friedl P. Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. The Journal of Cell Biology 2003, 160(2):267-277.
45. Yokozawa T., Kim Y.J. Piceatannol inhibits melanogenesis by its antioxydative actions. Biological & Pharmaceutical Bulletin 2007, 30(11):2007-2011.